Essential for hypertension management.

Investor Information

AtCor Medical Holdings Limited is a publicly-held company traded on the Australian Exchange (ASX) under the code ACG. AtCor Medical’s corporate headquarters are in Sydney, Australia.

AtCor Annual Report 2016

AtCor Annual Report 2015

AtCor Annual Report 2014

AtCor Annual Report 2013

AtCor Annual Report 2012

AtCor Annual Report 2011

AtCor Annual Report 2010

2 May 2016

Select Equities has recently initiated coverage of AtCor Medical

14 January 2016

Taylor Collison: Pharma slows, but long term thesis remains intact

1 April 2015

Value Creation Ahead Following CPT-1 Code Award

This information has been prepared by third parties and therefore AtCor Medical makes no representations about the accuracy, reliability, completeness or timeliness of the information. AtCor Medical does not necessarily endorse or approve the recommendations, assumptions and conclusions contained in the information. The information does not constitute financial advice and should not be relied on as such. You should seek expert financial advice in relation to the information.

Donal O’Dwyer, BEng., MBA
Independent Non-Executive Director
Chairman of the Board, Member of the Audit & Risk Committee
and Remuneration & Nomination Committee

Donal was appointed as a Director of the AtCor Group in September 2004 and became its Chairman in November 2004. He has extensive experience in the medical devices and cardiovascular sectors, having previously been worldwide president of Cordis Cardiology, the cardiology division of Johnson & Johnson.

Other directorships include Cochlear Ltd., Mesoblast Ltd. and Fisher & Paykel Healthcare Corporation Ltd.

Duncan Ross, BS
Managing Director and CEO

Duncan joined AtCor Medical as President in May 2006 and was subsequently appointed CEO and a Director of the AtCor Group in November 2006. He has more than 30 years of experience in the life sciences and medical devices industries. Before joining AtCor, Duncan was Group President of Fisher Scientific, and also held senior roles with Sysmex America and Baxter Healthcare.

Michael O’Rourke, A.M., MD, DSc.
Non-Executive Director

Michael is a co-founder of AtCor and has been a Director since the company’s inception in 1993. He is also the inventor of the technology on which SphygmoCor is based and remains one of the world’s leading experts in the field of cardiovascular physiology and medicine. He is co-author of the standard reference textbook McDonald’s Blood Flow in Arteries, has published more than 300 peer-reviewed articles and serves on the editorial boards of the journals Hypertension, Journal of Hypertension, American Journal of Hypertension and Journal of American Society of Hypertension.

Michael is a director of the Victor Chang Foundation.

R. King Nelson
Independent Non-Executive Director
Chairman of Remuneration & Nomination Committee, Member of Audit & Risk Committee

King was elected to the Board in November 2015. He brings more than 30 years of diverse experience and expertise with medical devices. He is currently President and CEO of Uptake Medical Corporation, a company focused on treatments for emphysema and lung cancer. Previously, he served as president and CEO of Kerberos Proximal Solutions, which was acquired by FoxHollow Technologies, and as president and CEO of VenPro, a heart valve business acquired by Medtronic. Both these companies specialized in devices for the cardiovascular system. Prior to that, he spent 19 years with Baxter International and American Hospital Supply Corporation in roles of increasing responsibility that included division president for Dade Diagnostics, Bentley Labs, and Baxter’s Perfusion Services.

David Brookes, MBBS, FACRRM, FAICD
Independent Non-Executive Director
Chairman of Audit & Risk Committee, member of Remuneration & Nomination Committee

David became a Director in November 2008. He is a Fellow of the Australian College of Rural and Remote Medicine and currently works as a general medical practitioner with extensive experience in rural Australia, especially in paediatric and procedural practice. David is also an experienced company director and is currently the Non-executive Chairman of Reproductive Health Sciences Ltd.

Peter Manley, BBus, CPA, ACIS
Chief Financial Officer & Company Secretary

Peter was appointed to the position of Company Secretary in March 2005. He also holds the position of Chief Financial Officer. Before joining AtCor Medical Holdings Limited, he was Company Secretary and CFO for Sirtex Medical Ltd, a publicly-listed medical device company. Prior to this, he held financial positions in a variety of large Australian and foreign-owned corporations.

Please visit AtCor Medical’s Share Registry site for additional information

© 2017 AtCor Medical Pty Ltd.

Most Recent Tweet